Market Tracker

06/24 5:16pm ET

MannKind Corp (NASDAQ:MNKD)

1.25
Delayed Data
As of Jun 24
 +0.01 / +0.81%
Today’s Change
0.64
Today|||52-Week Range
5.97
-13.79%
Year-to-Date

Today’s Trading

Previous close1.24
Today’s open1.11
Day’s range1.10 - 1.30
Volume14,839,659
Average volume (3 months)6,017,807
Market cap$511.1M
Dividend yield--
Data as of 4:00pm ET, 06/24/2016

Growth & Valuation

Earnings growth (last year)-78.43%
Earnings growth (this year)+74.18%
Earnings growth (next 5 years)+26.80%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book--

Competitors

 Today’s
change
Today’s
% change
CLVSClovis Oncology Inc-0.92-6.60%
PDLIPDL BioPharma Inc-0.07-2.23%
LOXOLoxo Oncology Inc-0.53-2.20%
AIMTAimmune Therapeutics...-0.86-6.99%
Data as of 4:00pm ET, 06/24/2016

Financials

Next reporting dateAugust 8, 2016
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$0.00
Annual profit (last year)-$368.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
CEO, CFO, Director, VP &
Head-Investor Relations
Matthew J. Pfeffer
Chief Medical Officer
Raymond W. Urbanski
Corporate headquarters
Valencia, California

Forecasts